General Practice in Shreveport, LA
14 verified general practice doctors in Shreveport.
General practice physicians provide broad, first-contact medical care for common conditions across all age groups.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Louisiana State Board of Medical Examiners
Dr. Karen Purdy, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ezekiel Wetzel, MD
General Practice
CMS Open Payments· $74.26 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$74.26
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 13,209 general practice doctors we've analyzed, about 25% received any industry payment (median $145 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US general practice doctors.
Payments to Ezekiel Wetzel do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Charles Sale, MD
General Practice
CMS Open Payments· $14.47 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$14.47
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,209 general practice doctors we've analyzed, about 25% received any industry payment (median $145 among those who did). This doctor's total ranks around the 75th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US general practice doctors.
Payments to Charles Sale do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jean Rousseau, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ronald Schneider, MD
General Practice
CMS Open Payments· $320.00 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$320.00
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,209 general practice doctors we've analyzed, about 25% received any industry payment (median $145 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US general practice doctors.
Payments to Ronald Schneider do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Laura Mitcham, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Julana Monti, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Eddie Johnson, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Natalia Luraguiz, MD
General Practice
CMS Open Payments· $126.92 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$126.92
Total received
8
Transactions
5
Paying companies
Top paying companies
Among the 13,209 general practice doctors we've analyzed, about 25% received any industry payment (median $145 among those who did). This doctor's total ranks around the 87th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US general practice doctors.
Payments to Natalia Luraguiz do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Pilar Sheplan Olsen, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Rafael Justiniano Magraner, MD
General Practice
CMS Open Payments· $593.81 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$593.81
Total received
10
Transactions
5
Paying companies
Top paying companies
Among the 13,209 general practice doctors we've analyzed, about 25% received any industry payment (median $145 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US general practice doctors.
Payments to Rafael Justiniano Magraner do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Alex Glotser, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Luis Martinez-Nater, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Betsy Ball, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.